Key facts
- Propel Bio Management, LLC filed SCHEDULE 13G for Milestone Pharmaceuticals Inc. Common Stock (MIST).
- Disclosed ownership: 9.9%.
- Date of event: 11 Jul 2025.
Propel Bio Management, LLC - 11 Jul 2025 SCHEDULE 13G Report for Milestone Pharmaceuticals Inc. Common Stock (MIST)
- Filing Manager
- Propel Bio Management, LLC
- Reporting Manager
- Propel Bio Management, LLC
- Symbol
- MIST
- Shares outstanding
- 89,506,929 shares
- Disclosed Ownership
- 8,861,186 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 23 Dec 2025, 14:20:47 UTC
- Date of event
- 11 Jul 2025
- SEC
- View on sec.gov
Key filing fact
Propel Bio Management, LLC disclosed 9.9% ownership in Milestone Pharmaceuticals Inc. Common Stock (MIST) on 11 Jul 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 23 Dec 2025, 14:20.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (4)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Propel Bio Management, LLC | 9.9% | 8,861,186 | 8,861,186 | 0 | Leen Kawas | Managing Member | |
| Leen Kawas | 9.9% | 8,861,186 | 8,861,186 | 0 | Leen Kawas | individually | |
| Richard Kayne | 9.9% | 8,861,186 | 8,861,186 | 0 | Richard Kayne | individually | |
| Propel Bio Partners LLC | 9.9% | 8,861,186 | 8,861,186 | 0 | Leen Kawas | Managing Member |
CIK / CUSIP context first